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IL-17: A Key Player in the P. acnes
Inflammatory Cascade?
Diane M. Thiboutot1, Alison M. Layton2 and E. Anne Eady2
Recent advances in our understanding of inflammatory skin diseases now afford
an opportunity to delve deeper into microbial/host interactions in acne. Agak
et al. report that Propionibacterium acnes induces IL-17 expression in peripheral
blood mononuclear cells and present new evidence that IL-17þ cells are found in
the perifollicular infiltrate of comedones. Additional studies are needed to assess
the clinical relevance of IL-17 in acne.
Journal of Investigative Dermatology (2014) 134, 307–310. doi:10.1038/jid.2013.400
Plewig and Kligman (2000) wrote that
‘‘Sebum is the fuel of the acne flame’’.
The question is ‘‘How did the fire get
started?’’.
In this issue, Agak et al. (2014)
present a series of experiments that sup-
port a role for IL-17 in the pathogenesis
of acne. They demonstrate that Propi-
onibacterium acnes induces IL-17
expression in human peripheral blood
mononuclear cells (PBMCs) from
healthy individuals in vitro and that
supernatants from cultures of P. acnes
incubated with PBMCs induce naive
CD4þCD45TAþ T cells to differen-
tiate into Th17 cells (expressing Th17,
RORa, and RORc) and Th1 cells (expre-
ssing IFNg). By using a panel of neutra-
lizing antibodies, they determined that
IL-1b, IL-6, and transforming growth
factor-b (TGFb) regulate P. acnes–
induced IL-17 responses as they do in
other systems. Furthermore, the authors
suggest that the clinical relevance for
these findings is supported by the identi-
fication of IL-17þ cells in perifollicular
infiltrates in biopsies of typical closed
comedone-type acne lesions. Before
concluding that these findings are rele-
vant in the pathogenesis of acne, links
need to be made between the in vitro
and in vivo data. For example, is
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P. acnes present universally in follicles
surrounded by an infiltrate containing
IL-17-positive cells and what type of
cells are they? In addition to providing
potential insight into acne pathogenesis,
these data raise questions regarding the
multiplicity of mechanisms by which
P. acnes interacts with immune cells
in vivo, the sequence of events that
initiates and terminates inflammatory
responses in acne and the possible role
of IL-17. Furthermore, demonstration of
the ability of all trans retinoic acid
(ATRA) and vitamin D to suppress
P. acnes–induced generation of Th17
cells suggests a potential new mecha-
nism of action whereby retinoids
and vitamin D might modulate acne
inflammation physiologically or even
pharmacologically.
How does P. acnes wage war in acne?
P. acnes is a commensal organism that
colonizes the pilosebaceous follicles of
people with and without acne. Although
not a classical pathogen, P. acnes have
the capacity to contribute to the genesis
of inflammatory acne via multiple path-
ways (Table 1). Several in vitro studies
demonstrate that P. acnes whole cells
or cell fractions stimulate cytokine
and matrix metalloproteinase release
from immune cells, keratinocytes, and
sebocytes (Kim et al., 2002; Liu et al.,
2005; Nagy et al., 2006; Lee et al.,
2010) (Figure 1a and b).
The mechanism by which P. acnes
exerts its effects on these cells in vivo is
unknown, perhaps via direct contact,
secreted factors, or secondary events
(Table 1). P. acnes resides mainly in
the microaerophilc deeper portions of
healthy follicles where it comes in con-
tact with follicular keratinocytes and
cells within the proximal region of the
sebaceous duct. Within comedones, it
multiplies within the sebum-filled lacu-
nae that form inside of the cornified
plugs. It can be envisioned that P. acnes
whole cells, cell fragments, and/or
secreted factors may exert proinflamma-
tory effects on follicular keratinocytes.
P. acnes comes in direct contact with
the cells within the dermis following
follicular rupture, a late finding in the
development of inflammatory acne
lesions (Plewig and Kligman, 2000).
Soluble factors, however, may escape
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from the duct once the perme-
ability barrier is disrupted, which
would occur much sooner than
follicular rupture.
As pointed out by Agak et al. (2014),
the mechanism by which P. acnes influ-
ences the development of Th17 cells
in the inflammatory infiltrate of acne is
not known. The authors expand upon a
hypothesis put forth previously by
Farrar and Ingham regarding the proce-
ssing of immunogenic P. acnes proteins
released into the follicle by Langerhans
cells, which would then be transport to
lymph nodes to activate naive T cells,
with subsequent migration of Th17 cells
back to the skin. Within this scenario, a
major question would be whether
P. acnes must be ingested and processed
by antigen-presenting cells before acti-
vating naive T cells to become Th17
cells. If antigen presentation by Langer-
hans cells is needed, then findings
generated from PBMCs in vitro might
not reflect in vivo findings. We know
that follicular rupture occurs late in acne
lesion development, leading to the
release of P. acnes, sebum, and cellu-
lar debris into the dermis, which
intensifies inflammation greatly. Under
these conditions, P. acnes or secreted
cytokines may interact with immune
cells within the dermis, also influen-
cing Th17 development.
The relative importance of IL-17
compared with other cytokines induced
in vitro by P. acnes, such as IL-8, IL-12,
IL12p40, IL-6, TNFa, IFNg, and IL-1b, is
not known. In terms of relative abun-
dance, Agak et al. (2014) demonstrate
that following P. acnes induction of
naive T cells 4.5% become Th1 cells,
whereas 1.4% become IL-17-expressing
Th17 cells. A similar question regarding
the relative importance of IL-17 in
psoriasis existed; it is only now
beginning to be answered in clinical
trials of agents that target IL-17.
Surprisingly, there is still a large gap
in our understanding of cytokine expres-
sion within acne lesions. Figure 1 com-
pares the expression of cytokines and
other selected mediators in acne lesions
in vivo with the mediators that have
been shown to be modulated by some
or all strains of P. acnes in vitro (Ingham
et al., 1992; Chronnell et al., 2001; Kim
et al., 2002; Jeremy et al., 2003; Kang
et al., 2005; Liu et al., 2005; Nagy et al.,
2005; Nagy et al., 2006; Trivedi et al.,
2006; Lee et al., 2010; Agak et al.,
2014). It is noteworthy that IL-6, IL-12,
IFNg, and TGFb have not been studied
in acne lesions; this information would
be of additional importance given that
acne has until now been considered to
be primarily a Th-1-mediated disease.
T cells cloned from acne lesions express
IFNg, which is consistent with a Th1
response (Mouser et al., 2003). It would
be of value to clone T cells from early
and late acne lesions to identify and
characterize the Th17 cells.
Where in acne lesion development might
IL-17 have a role?
Advances in immunology continue to
shift paradigms in our thinking about
common skin diseases. Psoriasis was
once thought to be a disorder of kera-
tinocyte differentiation, with secondary
Clinical Implications
 Data on IL-17 expression in closed comedones and induction by Propio-
nibacterium acnes are novel.
 Before translating this information into treatment considerations, clinical
relevance must be established.
 Key studies are needed to link the in vitro effects of P. acnes on IL-17 expression
in monocytes to the progression of inflammation in acne lesions over time.
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Figure 1. Comparison of cytokines expressed in acne lesions in vivo and in response to Propionibacterium acnes in vitro. (a) Cytokines expressed in acne lesions
from patients (Ingham et al., 1992; Chronnell et al., 2001; Jeremy et al., 2003; Kang et al., 2005; Trivedi et al., 2006; Agak et al., 2014). (b) Cytokines expressed
by various cell types in response to P. acnes stimulation in vitro (Kim et al., 2002; Liu et al., 2005; Nagy et al., 2006; Lee et al., 2010). Cytokines in italics are
those identified in Agak et al. (2014).
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inflammatory events. Clearly, this con-
cept has changed over the years, and it
has led to the discovery of novel bio-
logic therapies that target components
of the inflammatory cascade in psoria-
sis, including IL-17. Acne was thought
to result from a combination of follicu-
lar hyperkeratinization, proliferation of
P. acnes, and increased sebum produc-
tion, with inflammatory events occur-
ring subsequently. This paradigm began
to shift with elegant studies from Cun-
liffe’s group examining the inflamma-
tory infiltrate in early acne lesions.
Comedones clinically are noninflam-
matory lesions characterized by follicu-
lar hyperkeratinization. These lesions
were found to contain IL-1-like material
that was hypothesized to be released
by keratinocytes, thus initiating an
inflammatory cascade (Ingham et al.,
1992). A series of studies mapping
the progression of inflammatory lesions
from less than 6 hours up to 72 hours
revealed that CD4þ lymphocytes,
along with macrophages (CD68þ ),
were the earliest immune cells to
infiltrate sites of evolving inflammatory
lesions (Norris and Cunliffe, 1988;
Layton et al., 1998). Furthermore, sub-
clinical inflammation, consisting of the
same cell types in lower numbers, can
be found in otherwise normal follicles
from unaffected skin in acne patients,
suggesting that inflammation may
precede keratinocyte hyperproliferaton
(Jeremy et al., 2003). If inflammation
precedes comedone formation, it
may be less likely that P. acnes is
driving this early influx of inflam-
matory cells, given that in acne only a
minority (o20%) of healthy follicles
are colonized with viable P. acnes
(Leeming et al., 1988).
Th17 cells were not known to exist at
the time of the studies by Cunliffe’s
group. It would be interesting in view
of Agak’s report to speculate that the
early infiltrating CD4þ cells might
represent Th17 cells or Th1 cells drawn
in toward secreted factors from P. acnes.
In this case, could IL-17 represent the
spark for the acne flame? If IL-1a triggers
the nonspecific immune responses in
acne, as Jeremy et al. (2003) suggest,
P. acnes might augment this via Toll-like
receptor activation. Concomitantly or
subsequently, P. acnes may also initi-
ate specific cell-mediated responses via
the recruitment of different T-cell popu-
lations, perhaps depending on the type
of lesion and its cytokine mileu, type of
P. acnes, and the immune status of the
individual. Clearly, we are a long way
from knowing all of this, but perhaps it
should not be surprising that acne
lesions are so pleomorphic. A repeat of
the challenging studies of lesion mapp-
ing as done by the Cunliffe group using
today’s technologies is clearly needed.
A complete histological examination of
acne lesions over the course of lesion
development (including lesion resolu-
tion) and over a range of patient ages
may help establish a role for IL-17 in
acne. It is important to keep in mind that
factors other than P. acnes may also
influence IL-17 secretion in vivo.
How do ATRA and vitamin D suppress
P. acnes–induced IL-17 effects and what
are the therapeutic implications?
ATRA and vitamin D decrease the
expression of TLR2 on monocytes (Liu
et al., 2005). Studies from the Kim group
demonstrate that P. acnes induction of
IL-12, IL-1b, IL12p40, IL-6, and TNFa in
PBMCs is blocked in the presence of
neutralizing antibodies against TLR2
(Kim et al., 2002; Liu et al., 2005; Qin
et al., 2014). Th17 development is
regulated by IL-6, TGFb, and IL-1b.
Because IL-6 and IL-1b are key players
in Th17 cell differentiation, it is possible
that ATRA or vitamin D exerts its
suppressive effects on IL-17 induction
via TLR2 inhibition, in addition to
negative regulation of transcription of
IL-17, RORa, and RORc. Clinical
relevance for retinoic acid suppression
of TLR2 is also supported by the finding
that treatment of acne patients with oral
isotretinoin temporally reduces the
expression of TLR2 on PBMCs from
patients during the course of treatment
(Dispenza et al., 2012). Little is known
regarding a putative role for vitamin D
in acne apart from reports indicating
that vitamin D augments cathelicidin
expression in sebocytes, which in
combination with other antimicrobial
peptides can kill P. acnes (Nakatsuji
et al., 2010). Additional studies
regarding the importance of Th17 in
acne would be needed to support the
use of vitamin D in therapy. Data on the
dose–response of IL-17 suppression by
ATRA and vitamin D would also help
determine whether these effects are
relevant in vivo.
What new information does this study
bring?
By putting the spotlight on IL-17 and
Th17 cells, Agak et al. (2014) have
raised the possibility that acne is not
uniquely a Th-1 cell–mediated disease.
Their observations suggest that the
immune response in acne may be more
complex than thought previously. In
addition to showing that P. acnes can
induce the production of IFNg, a key
cytokine marker for Th-1 cells, they
have demonstrated that P. acnes can
Table 1. Mechanisms by which P. acnes may modulate inflammatory
responses in acne
Mechanism Significance
Production of tissue-destructive
enzymes
Damaged follicle walls, allowing contents (including intact bacteria
and auto-antigens) to escape into the dermis
Complement activation via the
alternate pathway
Complement C3 deposition, an early event in lesion formation
Activation of pattern recognition
receptors
Induction of innate immune responses and triggering the release of
proinflammatory cytokines
Production of chemoattractants Possible diffusion across intact follicle wall to attract leukocytes
T-cell mitogenic activity Nonspecific upregulation of T cell–mediated immune responses
Adjuvant activity Nonspecific upregulation of immune responses to unrelated antigens
Production of soluble antigens Possible diffusion across intact follicle walls
Production of particulate
antigens
Cell fragments induce a family of specific responses
Intracellular persistence Persistent inflammation
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modulate IL-17 and IL-22 production, as
well as the expression of IL-17 receptors
on PBMCs from healthy donors in vitro.
Looking ahead
This interesting and provocative work
by Agak et al. (2014) poses many
fascinating new questions relating to
initiating events in acne pathogenesis
and mechanisms of inflammation.
Further in vivo work should determine
whether some or all of these findings
have relevance to the clinical setting,
with a view toward informing the
development of novel therapies.
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New Insights into Acne Pathogenesis:
Propionibacterium Acnes Activates the
Inflammasome
Emmanuel Contassot1 and Lars E. French1
The precise contribution of the commensal bacterium Propionibacterium acnes
(P. acnes) in the inflammatory response associated with acne vulgaris remains
controversial. In this issue Qin et al. show that P. acnes induces robust IL-1b
secretion in monocytic cells by triggering the activation of the NLRP3 inflamma-
some. In vivo, the encounter of P. acnes and macrophages in the peri-follicular
dermis could locally result in the release of substantial amounts of IL-1b and
therefore exacerbate inflammation. Such findings suggest that molecules targeting
IL-1b and/or the NLRP3 inflammasome may constitute new treatment possibilities
for acne vulgaris.
Journal of Investigative Dermatology (2014) 134, 310–313. doi:10.1038/jid.2013.505
Acne vulgaris is a common inflamma-
tory skin disease affecting B80% of
individuals at some time during their
lives (Williams et al., 2012). The dis-
ease, affecting the pilo-sebaceous unit,
is a multifactorial process involving both
endogenous and exogenous factors,
including increased sebum production,
altered follicular keratinization, inflam-
mation, and bacterial colonization of
the pilo-sebaceous unit by Propioni-
bacterium acnes (P. acnes), a common
anaerobic Gram-positive commensal of
normal skin. Increased sebum pro-
duction and follicular hyperkeratosis
are thought to be initial events leading
to a change of the pilo-sebaceous milieu
that favors the proliferation of P. acnes
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